The assessment piece will be a 1,500 word essay, from one of the each cases outlined below. Students are encouraged to compare and contrast different treatments listed: with a focus on the challenges encountered through R&D and development: including discovery, delivery and refinements if appropriate. Case study: Tamiflu (oseltamivir) and Relenza (zanamivir) are classes of drugs known as neuraminidase inhibitors. Both drugs are thought to prevent and reduce symptoms of flu by stopping the influenza virus from spreading inside the body. Tamiflu is used to combat flu in patients two weeks of age and older whose symptoms have not lasted longer than two days. It can be used to prevent flu in patients aged one year and older. Relenza is used to tackle flu in patients aged seven years and older, and can be used for flu prevention in those aged five years and older. USE THE FOLLOWING TEMPLATE: Introduction: Drug discovery: of ‘oseltamivir’ of ‘zanamivir’ Drug Development: of ‘oseltamivir’ of ‘zanamivir’ Discussion/Conclusion
